GlassScriptPhysician profile
Jay M Shenaq
NPI 1255421483
$2,091.25
in general payments reported to CMS, 2019-2025
10 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $24.31 · 2021: $90.26 · 2022: $631 · 2023: $225 · 2024: $838 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $776 · Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $776.25 |
| Food and Beverage | $451.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $776.25 | 2024 | Durasorb Monofilament Mesh |
| Mentor Worldwide LLC | $592.75 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Surgical Innovation Associates, INC. | $320.86 | 2022 | |
| Sientra, INC. | $185.16 | 2019-2022 | |
| Tela Bio, INC. | $62.95 | 2020-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $56.62 | 2023 | Swiftset |
| Stryker Corporation | $32.75 | 2024 | Spy-Phi System |
| Kci USA, INC. | $22.13 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $22.10 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $19.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Shenaq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.